Home

pudota Imartele kotelo annkristin heine Unohtumaton Absay Susi lampaan vaatteissa

UKB | Oberärzte
UKB | Oberärzte

Loop | Annkristin Heine
Loop | Annkristin Heine

Kontakt | Kindertagesstätte Bluma Mekler | DRK-KiJu
Kontakt | Kindertagesstätte Bluma Mekler | DRK-KiJu

The PI3Kδ inhibitor idelalisib impairs the function of human dendritic  cells | Cancer Immunology, Immunotherapy
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells | Cancer Immunology, Immunotherapy

Ann-Kristin Sass on LinkedIn: #mixedreality #virtualreality #digitalhealth  #mr #vr #ar
Ann-Kristin Sass on LinkedIn: #mixedreality #virtualreality #digitalhealth #mr #vr #ar

Researchers release the brakes on the immune | EurekAlert!
Researchers release the brakes on the immune | EurekAlert!

Annkristin HEINE | Medical Doctor | Professor | University of Bonn -  Medical Center, Bonn | Haematology Oncology | Research profile
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile

Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk  inhibition in multiple myeloma | Experimental Hematology & Oncology | Full  Text
Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma | Experimental Hematology & Oncology | Full Text

Unter der Leitung von Frau Prof.... - Krebszentrum CIO Bonn | Facebook
Unter der Leitung von Frau Prof.... - Krebszentrum CIO Bonn | Facebook

Regulation of dectin-1–mediated dendritic cell activation by peroxisome  proliferator–activated receptor-gamma ligand troglitazone - ScienceDirect
Regulation of dectin-1–mediated dendritic cell activation by peroxisome proliferator–activated receptor-gamma ligand troglitazone - ScienceDirect

UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“
UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“

PDF) Clinical and immunological effects of mRNA vaccines in malignant  diseases
PDF) Clinical and immunological effects of mRNA vaccines in malignant diseases

Ann SCHMITZ | Heinrich-Heine-Universität Düsseldorf, Düsseldorf | HHU |  Neurochirurgische Klinik | Research profile
Ann SCHMITZ | Heinrich-Heine-Universität Düsseldorf, Düsseldorf | HHU | Neurochirurgische Klinik | Research profile

UKB NewsRoom | Tückischen Blutkrebs effektiv bekämpfen
UKB NewsRoom | Tückischen Blutkrebs effektiv bekämpfen

Rafa Argüello on X: "Excited, glad and nervous to be invited to share about  SCENITH to such an amazing audience at the @ImmunoSens ImmunoSensation  Cluster of Excellence - LIMES - Univ-Bonn See
Rafa Argüello on X: "Excited, glad and nervous to be invited to share about SCENITH to such an amazing audience at the @ImmunoSens ImmunoSensation Cluster of Excellence - LIMES - Univ-Bonn See

Ann-Kristin Grobe – Wissenschaftliche Hilfskraft im Team von Prof. Dr. Marc  Ziegele – Heinrich-Heine-Universität Düsseldorf | LinkedIn
Ann-Kristin Grobe – Wissenschaftliche Hilfskraft im Team von Prof. Dr. Marc Ziegele – Heinrich-Heine-Universität Düsseldorf | LinkedIn

Clinical and immunological effects of mRNA vaccines in malignant diseases |  Molecular Cancer | Full Text
Clinical and immunological effects of mRNA vaccines in malignant diseases | Molecular Cancer | Full Text

Ann-Kristin Müller – Stellvertretende Niederlassungsleiterin – Heine +  Beisswenger Gruppe | LinkedIn
Ann-Kristin Müller – Stellvertretende Niederlassungsleiterin – Heine + Beisswenger Gruppe | LinkedIn

Generation and functional characterization of MDSC-like cells
Generation and functional characterization of MDSC-like cells

Prof. Dr. Annkristin Heine
Prof. Dr. Annkristin Heine

Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's  Witness patient | Annals of Hematology
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient | Annals of Hematology

Erste Studie nach Satelliten-Modell gestartet - Uniklinik Köln
Erste Studie nach Satelliten-Modell gestartet - Uniklinik Köln

Axitinib dose-dependently induces apoptosis in the renal cell carcinoma  cell line A-498, but has no toxic effects on dendritic cells.
Axitinib dose-dependently induces apoptosis in the renal cell carcinoma cell line A-498, but has no toxic effects on dendritic cells.

Team | IMMEI
Team | IMMEI

Annkristin HEINE | Medical Doctor | Professor | University of Bonn -  Medical Center, Bonn | Haematology Oncology | Research profile
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile